The potential of emerging technologies is creating new markets quickly. BBIA has identified long-term investment opportunities — particularly in regenerative medicine, immune therapies, and genetics; and more broadly in the growing value of biological and medical data itself.
a. Stem Cells: Clinical trials have begun to produce positive results in everything from Age-related Macular Degeneration (AMD) to Parkinson’s, ALS and the aging process.
b. Immune Therapies: The incredible potential of immune-based therapies to treat cancer has been demonstrated definitively and already some of these therapies are being called cures for specific kinds of cancers such as blood cancers.
c. Genomics: The immediate and powerful consequence of this technology is to allow models of disease to be created far more quickly which greatly accelerates drug discovery and development.